Our clients’ presentations at EASL ~The Digital International Liver Congress™ 2020 ~
- UPCOMING EVENTS
Our clients presented data on treatment of NASH using STAMTM model at the EASL ~The Digital International Liver CongressTM 2020~ (August 27-29).
For detailed information, see the below URL.
Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis
Institution: OncoArendi Therapeutics SA (Paland)
Novel autophagy inducer, a4368 improves non-alcoholic steatohepatitis in mice
Institution: Autophagy Sciences (Korea)
2-deoxy-D-glucose encapsulated PLGA nanoparticles suppress hepatocellular carcinoma through cytotoxic effect and activation of antitumor immunity
Institution: Kawasaki Medical School (Japan)
GPNMB modulates hepatic steatogenesis and liver cancer
Institution: Heidelberg University (Germany)